Elevation Oncology Inc.

0.52
0.00 (0.95%)
At close: Feb 28, 2025, 3:59 PM
0.55
4.82%
After-hours: Feb 28, 2025, 05:09 PM EST

Elevation Oncology Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 39K 27K 18K 15K n/a
Gross Profit -39K -27K -18K -15K n/a
Operating Income -45.45M -94.55M -32.05M -17.28M -5.88M
Interest Income 3.9M n/a n/a n/a n/a
Pretax Income -45.67M -95.06M -32.04M -17.27M -5.88M
Net Income -45.7M -95.08M -32.04M -17.27M -5.88M
Selling & General & Admin 14.9M 15.83M 8.45M 1.8M 544K
Research & Development 25.43M 78.72M 23.59M 15.48M 5.34M
Other Expenses 5.11M -506K 7K 11K n/a
Operating Expenses 45.45M 94.55M 32.05M 17.28M 5.88M
Interest Expense 4.17M 479K n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a 543.18K
Cost & Expenses 45.45M 94.55M 32.05M 17.28M 5.88M
Income Tax 30K 25K -218.56K -191.3K -8.82K
Shares Outstanding (Basic) 34.08M 23.27M 23.21M 23.76M 23.76M
Shares Outstanding (Diluted) 34.08M 23.27M 23.21M 23.76M 23.76M
EPS (Basic) -1.34 -4.09 -1.38 -0.73 -0.25
EPS (Diluted) -1.34 -4.09 -1.38 -0.73 -0.25
EBITDA -41.47M -94.52M -32.03M -17.25M -5.88M
Depreciation & Amortization 39K 27K 18K 15K 3.57M